Role of serum anti-C1q antibodies as a biomarker for nephritis activity in pediatric and adolescent Egyptian female patients with SLE

Expert Opinion on Medical Diagnostics

Volumn 6, Issue 6, 2012, Pages 489-498

  Kader, Mohamed Salah Eldin Mohamed Abdel ^a   Elaziz, Mohamed Momtaz Abd ^b   Ahmed, Dina Hisham ^b  

^a Misr University for Science and Technology   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Anti C1q antibodies; Anti dsDNA; C3; C4; ELISA; Juvenile systemic lupus erythematosus; Lupus nephritis; Renal SLEDAI; Urinary proteins

Indexed keywords

COMPLEMENT COMPONENT C1Q ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADOLESCENT; ANTIBODY BLOOD LEVEL; AREA UNDER THE CURVE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PROTEIN URINE LEVEL; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL; URINARY EXCRETION; VALIDITY;

EID: 84867924212     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2012.715632     Document Type: Article

References (34)

1. Appel GB, Contreras G, Dooley MA, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 2009;20(5):1103-12
2. Bao H, Liu ZH, Xie HL, et al. Successful treatment of class V + IV lupus nephritis with multitarget therapy. J Am Soc Nephrol 2008;19(10):2001-10
3. Bowness P, Davies KA, Norsworthy PJ, Athanassiou P. Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 1994;87:455-64
4. Rovin BH, Zhang X. Biomarkers for lupus nephritis: the quest continues. Clin J Am Soc Nephrol 2009;4:1858-65
5. Fiehn C, Hajjar Y, Mueller K. Improved outcome of lupus nephritis during the past decade: importance of diagnosis and treatment. Ann Rheum Dis 2003;62:439
6. Gunnarsson I, Ronnelid J, Huang YH, et al. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 1997;36:32-7
7. Houssiau FA, Vasconcelos C, D'Cruz D, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 2004;50(12):3940
8. Moroni G, Radice A, Giammarresi G, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009;68(2):234-7
9. Siegert CE, Kazatchkine MD, Sjoholm A, Wurzner R. Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol 1999;116:4-8
10. Walport MJ. Complement. Part 1. N Engl J Med 2001;344:1058-66
11. Truedsson L, Bengtsson AA, Sturfelt G. Complement deficiencies and systemic lupus erythematosus. Autoimmunity 2007;40:560-6
12. Janko C, Schorn C, Grossmayer G, et al. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE). Autoimmun Rev 2008;8:12
13. Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 2006;21:3115-21
14. Shoenfeld Y, Szyper-Kravitz M, Witte T, et al. Autoantibodies against protective molecules-C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann NY Acad Sci 2007;1108:227-39
15. Ravelli A, Wisnieski JJ, Ramenghi B, et al. IgG autoantibodies to complement C1q in pediatric-onset SLE. Clin Exp Rheumatol 1997;15:215-19
16. Kozyro I, Perahud I, Sadallah S, et al. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Pediatrics 2006;117:1663-8
17. Brunner HI, Silverman ED, To T, et al. Sensitivity of the systemic lupus erhytematosus disease activity index, British Isles Lupus Assessement Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erhytematosus. Arthritis Rheum 1999;42:1360
18. Niaudet P. Treatment of lupus nephritis in children. Pediatr Nephrol 2000;14:158-66
19. Inflinger JA, Mosteller FM, Thibodeau LA, Ware JH. Biostatistics in clinical medicine. MacGraw-Hill, Inc; New York: 1994
20. Lipsky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001;2:764-6
21. Barilla-LaBarca ML, Atkinson JP. Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 2003;15:55-60
22. Agnello V. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum 1978;21:S146-52
23. Jennette JC, Hipp CG. Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens. Am J Clin Pathol 1985;83:415-20
24. Mannik M, Merrjll CE, Stamps LD, et al. Multiple autoantibodies form the glomerular immune deposits in patients with SLE. J Rheum 2003;30:1495-504
25. Moroni G, Tredelenburg M, Del Papa N, et al. Anti-C1q antibodies may help diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001;37:490-8
26. Meyer OC, Nicaise RP, Cadoudal N, et al. Anti-C1q antibodies antedate active glomerulonephritis in patients with SLE. Arthritis Res Ther 2009;11:R87
27. Moroni G, Radice A, Giammarresi G, et al. Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 2009;68:234-7
28. Trendelenburg M, Lopez-Trascasa M, Potlukova E, et al. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 2006;21:3115-21
29. Mok CC, Ho LY, Leung HW, Wong LG. Performance of anti-C1q, antinucleosome, and and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Transl Res 2010;156:320-5
30. Bigler C, Hopfer H, Danner D, et al. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis. Nephrol Dial Transplant 2011;26:1220-8
31. Sinico RA, Rimoldi L, Radice A, et al. Anti-C1q autoantibodies in lupus nephritis. Ann NY Acad Sci 2009;1173:47-51
32. Jesus A, Silva CA, Carneiro-Sampaio M, et al. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus. Contemporary challenges in autoimmunity. Ann NY Acad Sci 2009;1173:235-8
33. Ho A, Barr SG, Magder LS, Petri M. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 2001;44(10):2350-7
34. Ricker DM, Hebert LA, Rohde R, et al. Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 1991;18(6):686-8